IL-6 in diabetes and cardiovascular complications

130Citations
Citations of this article
236Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

IL-6 is a pleiotropic cytokine that participates in normal functions of the immune system, haematopoiesis, metabolism, as well as in the pathogenesis of metabolic and cardiovascular diseases. Both pro- and anti-inflammatory roles of IL-6 have been described, which are distinguished by different cascades of signalling transduction, namely classic and trans-signalling. The present review summarizes the basic principles of IL-6 signalling and discusses its roles in diabetes and associated cardiovascular complications, with emphasis on the different outcomes mediated by the two modes of IL-6 signalling and the value of developing therapeutic strategies to specifically target the deleterious trans-signalling of IL-6. © 2014 The British Pharmacological Society.

Cite

CITATION STYLE

APA

Qu, D., Liu, J., Lau, C. W., & Huang, Y. (2014). IL-6 in diabetes and cardiovascular complications. British Journal of Pharmacology. John Wiley and Sons Inc. https://doi.org/10.1111/bph.12713

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free